Helix BioPharma Corp. :: New Directions in Cancer Therapy

Management Team

Donald H. Segal, Ph.D.
Chairman and CEO

Frank Michalargias, CA
Chief Financial Officer

John M. Docherty, M.Sc.
President and COO

Heman Chao, Ph.D.
Chief Scientific Officer